Myriad Genetics Inc
XHAM:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XHAM:MYD
|
US |
|
CoStar Group Inc
NASDAQ:CSGP
|
US |
|
S
|
South Harz Potash Ltd
ASX:SHP
|
AU |
|
M
|
Motos America Inc
OTC:MTAM
|
US |
|
G
|
Good Gamer Entertainment Inc
XTSX:GOOD
|
CA |
|
Tekfen Holding AS
IST:TKFEN.E
|
TR |
|
GoPro Inc
NASDAQ:GPRO
|
US |
|
Tamawood Ltd
ASX:TWD
|
AU |
|
Orkla ASA
OSE:ORK
|
NO |
|
Jiangsu Eazytec Co Ltd
SSE:688258
|
CN |
|
I
|
Interra Resources Ltd
SGX:5GI
|
SG |
|
Umicore SA
OTC:UMICY
|
BE |
|
Cardlytics Inc
NASDAQ:CDLX
|
US |
|
Squarespace Inc
NYSE:SQSP
|
US |
|
K
|
KolmarBNH Co Ltd
KOSDAQ:200130
|
KR |
|
H
|
Halo Microelectronics Co Ltd
SSE:688173
|
CN |
|
Orkla ASA
F:OKL0
|
NO |
|
Asia Pile Holdings Corp
TSE:5288
|
JP |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
437.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 119.9m USD. This includes both short-term (0 USD) and long-term (119.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
